Loading...
| A10849 | Pages: 170 | Apr 2021 | 6541 Views | | |
| Author(s) : Aniket Kadam , Roshan Deshmukh | Tables: 87 | Charts: 42 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the U.s. Baby Infant Formula Market
Request Now !The U.S. baby infant formula market size was valued at $3,653 million in 2019, and is projected to reach $5,811 million by 2027, registering a CAGR of 5.8% from 2021 to 2027.
Baby infant formula serves as an ideal alternative suitable for infant consumption, which mimics the nutritional composition of breast milk as closely as possible. Although physicians recommend breast milk for optimal infant nutrition, it may not always be possible, suitable, or solely adequate. Baby infant formula consists of various nutrients such as vitamins, proteins, carbohydrates, fat, linoleic acid, and prebiotics that help in the overall development of the infants.
Get more information on this report : Request Sample Pages
Increasing participation of women in the labor force in the U.S. is a key factor driving the growth of the U.S. baby infant formula market. For instance, according to the U.S. Bureau of Statistics, the working women population has increased from 57.1% in 2018 to 57.5% in 2020. The changing lifestyle of the middle-class population due to rapid urbanization and rising disposable is boosting the U.S. baby infant formula market growth. Moreover, it is perceived that baby infant formulas are rich in nutrients and supplements the growth of the baby is another factor driving the U.S. baby infant formula market. Furthermore, increasing health consciousness among the consumers in the U.S. is boosting the demand for the baby infant formula.
The outbreak of the COVID-19 pandemic had positively impacted the U.S. baby infant formula market. Baby infant formula is an essential item and during the lockdowns the demand witnessed an upsurge in the U.S. owing to the panic buying for at-home consumption during the initial phase of the pandemic. The development of online platforms such as telemedicine and e-commerce greatly contributed to the revenue generation in the U.S. baby infant formula market during the lockdown period. In the present scenario, consumers have become more health conscious and prefer minimally processed food and natural drinks for their babies. Thus, baby infant formula free from ingredients such as added sugar, sodium, and preservatives is expected to present new opportunities for manufacturers in the U.S. baby infant formula market. Moreover, manufacturers are focused on organic contents by removing the genetically modified ingredients (GMOs), synthetic pesticides, and fertilizers in the feeds of cows. Thus, the milk used in the baby infant formula is certified as organic. Thus, shift in preference toward organic food & drink is anticipated to offer remunerative opportunities for the expansion of the U.S. baby infant formula market during the forecast period.Â
Get more information on this report : Request Sample Pages
According to the U.S. baby infant formula market analysis, the U.S. baby infant formula market is segmented into product type, ingredient, distribution channel, and point of sale (POS). On the basis of product type, the market is categorized into infant milk, follow-on milk, specialty baby milk, and growing-up milk. In 2019, the infant milk segment dominated the U.S. market due its popularity among customers as the healthy and nutritious alternative to the breast-milk and better convenience. Various infant milks are supplemented with probiotics that prevents diarrhea, ease colic, and lowers the risk of allergies in infants. However, growing-up milk segment is expected to be the fastest-growing during the forecast period. Growing-up milk products are intended for children between 1 and 3 years of age, and these products are increasingly being introduced into the diets of young children. Growing-up milk helps to compensate nutritional deficiencies, which may occur in the transition phase of infant nutrition to family food. It is very rich in vitamin and calcium required for the normal growth.Â
Get more information on this report : Request Sample Pages
Based on ingredient, the carbohydrate segment accounts for the highest market share because carbohydrate is essential for the proper growth and development of the infants. Vitamin segment is expected to be the fastest-growing segment as vitamins are compulsory requirement for the growth, strong bones, healthy teeth, healthy red blood cells, and healthy nerve cells.
Based on the distribution channel, the hypermarkets segment dominated the market due to the facilities provided to customers such as reasonable prices, conveniences, and availability of desired brands and products. Hypermarkets are the most popular place for buying things among the U.S. population. However, Pharmacy/medical stores segment is expected to be the fastest growing segment due to the unawareness about the ingredients in infant formula and issues related to baby food safety. Hence, parents' belief on doctors and pediatricians is high and this factor drives the growth of the pharmacy/medical stores segment.
Get more information on this report : Request Sample Pages
On the basis of point of sale (POS), the OTC segment holds the highest U.S. baby infant formula market share as over-the-counter (OTC) is the most popular POS because most of the babies are hypoallergenic and requires no special attention on consuming infant formula. As per the U.S. baby infant formula market forecast, the OTC segment is expected to dominate in the forthcoming years.
The players operating in the U.S. baby infant formula market have adopted various developmental strategies to expand their market share, exploit the U.S. baby infant formula market opportunity, and increase profitability in the market. The key players profiled in this report include Abbott Laboratories, Arla Foods, Bobbie, Campbell Soups Company, Dana Dairy Group, Ltd., Danone S.A., D-Signstore, Else Nutrition Holdings, Inc., Hipp GmbH & Co. Vertrieb KG, Holle Baby Food AG, Kabrita USA, Nature’s One, LLC., Nestle S.A., Reckitt Benckiser Group Plc., and The Hain Celestial Group, Inc.Â
Get more information on this report : Request Sample Pages
Key Benefits For Stakeholders
Key Market Segments
Key Market Players
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for the stakeholder
1.3.Key market segments
1.4.Research methodology
1.4.1.Primary Research
1.4.2.Secondary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key finding of the study
2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five force analysis
3.3.1.Bargaining power of suppliers
3.3.2.Bargaining power of buyers
3.3.3.Threat of new entrants
3.3.4.Threat of substitutes
3.3.5.Intensity of competitive rivalry
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1.Increase in number of women participation in labor force
3.4.1.2.High nutritional content of infant formula
3.4.2.Restraint
3.4.2.1.Concerns related to food safety
3.4.2.2.Government initiatives to promote breastfeeding
3.4.3.Opportunity
3.4.3.1.Shift in preference toward organic baby food & drinks
3.4.3.2.Developments in technology result in emergence of new products
3.4.3.3.Extensive research on prebiotic and probiotics in baby food
3.5.Value chain analysis
3.6.Impact of key regulation
3.7.U.S. Baby Infant Formula Market: COVID-19 Impact Analysis
CHAPTER 4:U.S. BABY INFANT FORMULA MARKET, BY PRODUCT TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Infant milk
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast
4.3.Follow-on milk
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.4.Specialty baby milk
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast
4.4.3.Market size and forecast
4.5.Growing-up milk
4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast
CHAPTER 5:U.S. BABY INFANT FORMULA MARKET, BY INGRIDIENT
5.1.Overview
5.1.1.Market size and forecast
5.2.Carbohydrate
5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast
5.3.Fat
5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast
5.4.Protein
5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast
5.5.Minerals
5.5.1.Key market trends, growth factors, and opportunities
5.5.2.Market size and forecast
5.6.Vitamins
5.6.1.Key market trends, growth factors, and opportunities
5.6.2.Market size and forecast
5.7.Others
5.7.1.Key market trends, growth factors, and opportunities
5.7.2.Market size and forecast
CHAPTER 6:U.S. BABY INFANT FORMULA MARKET, BY DISTRIBUTION CHANNEL
6.1.Overview
6.1.1.Market size and forecast
6.2.Hypermarkets
'6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast
6.3.Supermarkets
6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast
6.4.Pharmacy/medical stores
6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast
6.5.Specialty stores
6.5.1.Key market trends, growth factors, and opportunities
6.5.2.Market size and forecast
6.6.Hard discounter stores
6.6.1.Key market trends, growth factors, and opportunities
6.6.2.Market size and forecast
6.7.Others
6.7.1.Key market trends, growth factors, and opportunities
6.7.2.Market size and forecast
CHAPTER 7:COMPETITION LANDSCAPE
7.1.Top winning strategies
7.2.Product mapping
7.3.Competitive dashboard
7.4.Competitive heat map
7.5.Brand positioning analysis
7.6.Key developments
7.6.1.Acquisition
7.6.2.Agreement
7.6.3.Product launch
CHAPTER 8:COMPANY PROFILES
8.1.ABBOTT LABORATORIES
8.1.1.Company snapshot
8.1.2.Operating business segments
8.1.3.Product portfolio
8.1.4.Distribution channel
8.1.5.R&D expenditure
8.1.6.Business performance
8.2.ARLA FOODS AMBA
8.2.1.Company snapshot
8.2.2.Operating business segments
8.2.3.Product portfolio
8.2.4.Distribution channel
8.2.5.R&D expenditure
8.2.6.Business performance
8.2.7.Key strategic moves and developments
8.3.BOBBIE
8.3.1.Company snapshot
8.3.2.Product portfolio
8.3.3.Distribution channel
8.3.4.Key strategic moves and developments
8.4.CAMPBELL SOUPS COMPANY
8.4.1.Company snapshot
8.4.2.Operating business segments
8.4.3.Product portfolio
8.4.4.Distribution channel
8.4.5.R&D expenditure
8.4.6.Business performance
8.5.DANA DAIRY GROUP LTD.
8.5.1.Company snapshot
8.5.2.Product portfolio
8.5.3.Distribution channel
8.5.4.Key strategic moves and developments
8.6.DANONE SA
8.6.1.Company snapshot
8.6.2.Operating business segments
8.6.3.Product portfolio
8.6.4.Distribution channel
8.6.5.Business performance
8.7.D-SIGNSTORE
8.7.1.Company snapshot
8.7.2.Product portfolio
8.7.3.Distribution channel
8.8.ELSE NUTRITION HOLDINGS INC
8.8.1.Company snapshot
8.8.2.Product portfolio
8.8.3.Distribution channel
8.8.4.Key strategic moves and developments
8.9.HIPP GMBH & CO. VERTRIEB KG
8.9.1.Company snapshot
8.9.2.Product portfolio
8.9.3.Distribution channel
8.10.HOLLE BABY FOOD AG
8.10.1.Company snapshot
8.10.2.Product portfolio
8.10.3.Distribution channel
8.11.KABRITA USA
8.11.1.Company snapshot
8.11.2.Product portfolio
8.11.3.Distribution channel
8.12.NATURE’S ONE, LLC
8.12.1.Company snapshot
8.12.2.Product portfolio
8.12.3.Distribution channel
8.12.4.Key strategic moves and developments
8.13.NESTLE S.A.
8.13.1.Company snapshot
8.13.2.Operating business segments
8.13.3.Product portfolio
8.13.4.Distribution channel
8.13.5.Business performance
8.13.6.Key strategic moves and developments
8.14.RECKITT BENCKISER GROUP PLC
8.14.1.Company snapshot
8.14.2.Operating business segments
8.14.3.Product portfolio
8.14.4.Distribution channel
8.14.5.R&D expenditure
8.14.6.Business performance
8.15.THE HAIN CELESTIAL GROUP, INC.
8.15.1.Company snapshot
8.15.2.Product portfolio
8.15.3.Distribution channel
8.15.4.Business performance
LIST OF TABLES
TABLE 01.U.S. BABY INFANT FORMULA MARKET VALUE, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 02.U.S. BABY INFANT FORMULA MARKET VOLUME, BY PRODUCT TYPE, 2019–2027 (KILOTON)
TABLE 03.U.S. BABY INFANT MILK MARKET VALUE, 2019–2027 ($MILLION)
TABLE 04.U.S. BABY INFANT MILK MARKET VOLUME, 2019–2027 (KILOTON)
TABLE 05.U.S. FOLLOW-ON MILK MARKET VALUE, 2019–2027 ($MILLION)
TABLE 06.U.S. FOLLOW-ON MILK MARKET VOLUME , 2019–2027 (KILOTON)
TABLE 07.U.S. SPECIALTY BABY MILK MARKET VALUE, 2019–2027 ($MILLION)
TABLE 08.U.S. SPECIALTY BABY MILK MARKET VOLUME, 2019–2027 (KILOTON)
TABLE 09.U.S. BABY INFANT FORMULA MARKET VALUE, BY POINT OF SALE, 2019–2027 ($MILLION)
TABLE 10.U.S. GROWING-UP MILK MARKET VALUE , 2019–2027 ($MILLION)
TABLE 11.U.S. GROWING-UP MILK MARKET VOLUME , 2019–2027 (KILOTON)
TABLE 12.U.S. BABY INFANT FORMULA MARKET VALUE, BY INGREDIENT, 2019–2027 ($MILLION)
TABLE 13.U.S. BABY INFANT FORMULA MARKET VALUE FOR CARBOHYDRATE, 2019–2027 ($MILLION)
TABLE 14.U.S. BABY INFANT FORMULA MARKET VALUE FOR FAT, 2019–2027 ($MILLION)
TABLE 15.U.S. BABY INFANT FORMULA MARKET VALUE FOR PROTEIN, 2019–2027 ($MILLION)
TABLE 16.U.S. BABY INFANT FORMULA MARKET VALUE FOR MINERALS, 2019–2027 ($MILLION)
TABLE 17.U.S. BABY INFANT FORMULA MARKET VALUE FOR VITAMINS, 2019–2027 ($MILLION)
TABLE 18.U.S. BABY INFANT FORMULA MARKET VALUE FOR OTHERS, 2019–2027 ($MILLION)
TABLE 19.U.S. BABY INFANT FORMULA MARKET VALUE, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 20.U.S. BABY INFANT FORMULA MARKET VALUE FOR HYPERMARKET, 2019–2027 ($MILLION)
TABLE 21.U.S. BABY INFANT FORMULA MARKET VALUE FOR SUPERMARKET, 2019–2027 ($MILLION)
TABLE 22.U.S. BABY INFANT FORMULA MARKET VALUE FOR PHARMACY/MEDICAL STORES, 2019–2027 ($MILLION)
TABLE 23.U.S. BABY INFANT FORMULA MARKET VALUE FOR SPECIALTY STORES, 2019–2027 ($MILLION)
TABLE 24.U.S. BABY INFANT FORMULA MARKET VALUE FOR HARD DISCOUNTER STORES, 2019–2027 ($MILLION)
TABLE 25.U.S. BABY INFANT FORMULA MARKET VALUE FOR OTHERS, 2019–2027 ($MILLION)
TABLE 26.ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 27.ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 28.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 29.ABBOTT LABORATORIES: DISTRIBUTION CHANNEL
TABLE 30.ABBOTT LABORATORIES: R&D EXPENDITURE, 2017–2019 ($MILLION)
TABLE 31.ABBOTT LABORATORIES: NET SALES, 2017–2019 ($MILLION)
TABLE 32.ARLA FOODS AMBA: COMPANY SNAPSHOT
TABLE 33.ARLA FOODS AMBA: OPERATING SEGMENTS
TABLE 34.ARLA FOODS AMBA: PRODUCT PORTFOLIO
TABLE 35.ARLA FOODS AMBA: DISTRIBUTION CHANNEL
TABLE 36.ARLA FOODS AMBA: R&D EXPENDITURE, 2017–2019 ($MILLION)
TABLE 37.ARLA FOODS: NET SALES, 2017–2019 ($MILLION)
TABLE 38.BOBBIE: COMPANY SNAPSHOT
TABLE 39.BOBBIE: PRODUCT PORTFOLIO
TABLE 40.BOBBIE: DISTRIBUTION CHANNEL
TABLE 41.CAMPBELL SOUP COMPANY: COMPANY SNAPSHOT
TABLE 42.CAMPBELL SOUP COMPANY: OPERATING SEGMENTS
TABLE 43.CAMPBELL SOUP COMPANY: PRODUCT PORTFOLIO
TABLE 44.CAMPBELL SOUP COMPANY: DISTRIBUTION CHANNEL
TABLE 45.CAMPBELL SOUP COMPANY: R&D EXPENDITURE, 2017–2019 ($MILLION)
TABLE 46.CAMPBELL SOUP COMPANY: NET SALES, 2017–2019 ($MILLION)
TABLE 47.DANA DAIRY GROUP LTD.: COMPANY SNAPSHOT
TABLE 48.DANA DAIRY GROUP LTD: PRODUCT PORTFOLIO
TABLE 49.DANA DAIRY GROUP LTD: DISTRIBUTION CHANNEL
TABLE 50.DANONE SA: COMPANY SNAPSHOT
TABLE 51.DANONE SA: OPERATING SEGMENTS
TABLE 52.DANONE SA: PRODUCT PORTFOLIO
TABLE 53.DANONE SA: DISTRIBUTION CHANNEL
TABLE 54.DANONE SA: NET SALES, 2017–2019 ($MILLION)
TABLE 55.D-SIGNSTORE: COMPANY SNAPSHOT
TABLE 56.D-SIGNSTORE: PRODUCT PORTFOLIO
TABLE 57.D-SIGNSTORE: DISTRIBUTION CHANNEL
TABLE 58.ELSE NUTRITION HOLDINGS INC: COMPANY SNAPSHOT
TABLE 59.ELSE NUTRITION HOLDINGS INC: PRODUCT PORTFOLIO
TABLE 60.ELSE NUTRITION HOLDINGS INC: DISTRIBUTION CHANNEL
TABLE 61.HIPP GMBH & CO. VERTRIEB KG: COMPANY SNAPSHOT
TABLE 62.HIPP GMBH & CO. VERTRIEB KG: PRODUCT PORTFOLIO
TABLE 63.HIPP GMBH & CO. VERTRIEB KG: DISTRIBUTION CHANNEL
TABLE 64.HOLLE BABY FOOD AG: COMPANY SNAPSHOT
TABLE 65.HOLLE BABY FOOD AG: PRODUCT PORTFOLIO
TABLE 66.HOLLE BABY FOOD AG: DISTRIBUTION CHANNEL
TABLE 67.KABRITA USA: COMPANY SNAPSHOT
TABLE 68.KABRITA USA: PRODUCT PORTFOLIO
TABLE 69.KABRITA USA: DISTRIBUTION CHANNEL
TABLE 70.NATURE’S ONE, LLC : COMPANY SNAPSHOT
TABLE 71.NATURE’S ONE, LLC: PRODUCT PORTFOLIO
TABLE 72.NATURE’S ONE, LLC: DISTRIBUTION CHANNEL
TABLE 73.NESTLE S.A: COMPANY SNAPSHOT
TABLE 74.NESTLE S.A: OPERATING SEGMENTS
TABLE 75.NESTLE S.A: PRODUCT PORTFOLIO
TABLE 76.NESTLE S.A: DISTRIBUTION CHANNEL
TABLE 77.NESTLE S.A: NET SALES, 2017–2019 ($MILLION)
TABLE 78.RECKITT BENCKISER GROUP PLC.: COMPANY SNAPSHOT
TABLE 79.RECKITT BENCKISER GROUP PLC: OPERATING SEGMENTS
TABLE 80.RECKITT BENCKISER GROUP PLC: PRODUCT PORTFOLIO
TABLE 81.RECKITT BENCKISER GROUP PLC: DISTRIBUTION CHANNEL
TABLE 82.RECKITT BENCKISER GROUP PLC.: R&D EXPENDITURE, 2017–2019 ($MILLION)
TABLE 83.RECKITT BENCKISER GROUP PLC.: NET SALES, 2017–2019 ($MILLION)
TABLE 84.THE HAIN CELESTIAL GROUP, INC.: COMPANY SNAPSHOT
TABLE 85.THE HAIN CELESTIAL GROUP, INC: PRODUCT PORTFOLIO
TABLE 86.THE HAIN CELESTIAL GROUP, INC: DISTRIBUTION CHANNEL
TABLE 87.THE HAIN CELESTIAL GROUP, INC.: NET SALES, 2018–2020 ($MILLION)
LIST OF FIGURES
FIGURE 01.KEY MARKET SEGMENTS
FIGURE 02.U.S. BABY INFANT FORMULA MARKET SNAPSHOT, 2021–2027
FIGURE 03.TOP INVESTMENT POCKETS, 2019
FIGURE 04.LOW BARGAINING POWER OF SUPPLIERS
FIGURE 05.LOW BARGAINING POWER OF BUYERS
FIGURE 06.LOW THREAT OF NEW ENTRANTS
FIGURE 07.LOW THREAT OF SUBSTITUTES
FIGURE 08.MODERATE INTENSITY OF COMPETITIVE RIVALRY
FIGURE 09.MARKET DYNAMIC ANALYSIS
FIGURE 10.U.S. BABY INFANT FORMULA MARKET SHARE, BY PRODUCT TYPE, 2019 (%)
FIGURE 11.U.S. BABY INFANT FORMULA MARKET SHARE, BY INGRIDIENT, 2019 (%)
FIGURE 12.U.S. BABY INFANT FORMULA MARKET SHARE, BY DISTRIBUTION CHANNEL, 2019 (%)
FIGURE 13.TOP WINNING STRATEGIES, BY YEAR, 2018–2021*
FIGURE 14.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2021* (%)
FIGURE 15.TOP WINNING STRATEGIES, BY COMPANY, 2018–2021*
FIGURE 16.PRODUCT MAPPING OF TOP 15 KEY PLAYERS
FIGURE 17.COMPETITIVE DASHBOARD OF TOP 15 KEY PLAYERS
FIGURE 18.COMPETITIVE HEATMAP OF TOP 15 KEY PLAYERS
FIGURE 19.ABBOTT LABORATORIES: R&D EXPENDITURE, 2017–2019 ($MILLION)
FIGURE 20.ABBOTT LABORATORIES: NET SALES, 2017–2019 ($MILLION)
FIGURE 21.ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 22.ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 23.ARLA FOODS AMBA: R&D EXPENDITURE, 2017–2019 ($MILLION)
FIGURE 24.ARLA FOODS AMBA: NET SALES, 2017–2019 ($MILLION)
FIGURE 25.ARLA FOODS AMBA: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 26.ARLA FOODS AMBA: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 27.CAMPBELL SOUP COMPANY: R&D EXPENDITURE, 2017–2019 ($MILLION)
FIGURE 28.CAMPBELL SOUP COMPANY: NET SALES, 2017–2019 ($MILLION)
FIGURE 29.CAMPBELL SOUP COMPANY: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 30.CAMPBELL SOUP COMPANY: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 31.DANONE SA: NET SALES, 2017–2019 ($MILLION)
FIGURE 32.DANONE SA: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 33.DANONE SA: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 34.NESTLE S.A: NET SALES, 2017–2019 ($MILLION)
FIGURE 35.NESTLE S.A: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 36.NESTLE S.A: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 37.RECKITT BENCKISER GROUP PLC.: R&D EXPENDITURE, 2017–2019 ($MILLION)
FIGURE 38.RECKITT BENCKISER GROUP PLC.: NET SALES, 2017–2019 ($MILLION)
FIGURE 39.RECKITT BENCKISER GROUP PLC. REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 40.RECKITT BENCKISER GROUP PLC. REVENUE SHARE BY REGION, 2019 (%)
FIGURE 41.THE HAIN CELESTIAL GROUP, INC.: NET SALES, 2018–2020 ($MILLION)
FIGURE 42.THE HAIN CELESTIAL GROUP, INC: REVENUE SHARE BY SEGMENT, 2020 (%)
Based on the insights of various CXOs’ of leading companies, the market has witnessed increase in launch activities and promotion of baby infant formula in the U.S. In addition, recommendation by physicians to use infant formula for babies up to 12 months as a substitute to breastmilk has changed the perception of people, leading to its high consumption. The brand name, level of nutrition, and safety of ingredients play a vital role in influencing the purchase decisions of consumers for baby infant formula products. Americans have gradually become conscious regarding the ingredients, which go into the making of their baby infant formula products, hence, tend to prefer specific trusted brands that cater to their requirements.
In 2019, infant milk accounted for the major market share, and is expected to continue its dominance during the forecast period. CXOs are optimistic about the growth of baby infant formula market in U.S. market, owing to the introduction of organic ingredients in infant products. In addition, hectic lifestyle of people, increase in participation of women in the labor force, and convenience in feeding babies have led to higher consumption of baby infant formula.
However, CXOs further added that concerns related to food safety and decline in birth rate may hamper the market growth. Moreover, consumers tend to purchase products, which are labeled as recyclable, or easy to recycle, since they are becoming increasingly environmentally conscious. Hence, eco-friendly packaged products help to influence the decision of eco-conscious parents up to a certain extent.
Â
A. The U.S. baby infant formula market size was valued at $3,653 million in 2019, and is projected to reach $5,811 million by 2027, registering a CAGR of 5.8% from 2021 to 2027 due to its growing demand because it has various nutrients content such as vitamins, proteins, carbohydrates, fat, linoleic acid, and prebiotics that help in the overall development of the infants.
A. The key players profiled in this report include Abbott Laboratories, Arla Foods, Bobbie, Campbell Soups Company, Dana Dairy Group, Ltd., Danone S.A., D-Signstore, Else Nutrition Holdings, Inc., Hipp GmbH & Co. Vertrieb KG, Holle Baby Food AG, Kabrita USA, Nature’s One, LLC., Nestle S.A., Reckitt Benckiser Group Plc., and The Hain Celestial Group, Inc.
A. https://www.alliedmarketresearch.com/request-sample/11214
A. The U.S. baby infant formula market is growing at a CAGR of 5.8% from 2021 to 2027 due to its growing demand and adoption because it is a substitute for breastmilk. It has various nutrient contents such as proteins, vitamins, fat, linoleic acid, and carbohydrates that is essential for the growth of the infants.
A. The manufacturers are focused on organic contents by removing the genetically modified ingredients (GMOs), synthetic pesticides, and fertilizers in the feeds of cows. Thus, the milk used in the baby infant formula is certified as organic. Thus, shift in preference toward organic food & drink is anticipated to offer remunerative opportunities for the expansion of the U.S. baby infant formula market during the forecast period.
A. According to the U.S. baby infant formula market analysis, the U.S. baby infant formula market is segmented into product type, ingredient, distribution channel, and point of sale (POS). On the basis of product type, the market is categorized into infant milk, follow-on milk, specialty baby milk, and growing-up milk. Based on ingredient, it is segmented into carbohydrate, fat, protein, minerals, vitamins, and others. On the basis of distribution channel, it is classified as hypermarkets, supermarkets, pharmacy/medical stores, specialty stores, hard discounter stores, and others, and based on Point of Sale, it is segmented into prescription Based and OTC.
A. The U.S. baby infant formula market report analyzes the opportunities, trends, and forecasts for the period starting from 2021 to 2027.
A. In 2019, the infant milk segment dominated the U.S. market due its popularity among customers as the healthy and nutritious alternative to the breast-milk and better convenience. Various infant milks are supplemented with probiotics that prevents diarrhea, ease colic, and lowers the risk of allergies in infants.
A. The outbreak of the COVID-19 pandemic had positively impacted the U.S. baby infant formula market. Baby infant formula is an essential item and during the lockdowns the demand witnessed an upsurge in the U.S. owing to the panic buying for at-home consumption during the initial phase of the pandemic.
Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
